Segment and Geographic Information

3 Months Ended

Mar. 31, 2015

Segment Reporting [Abstract]

Segment and Geographic Information

10. SEGMENT AND GEOGRAPHIC INFORMATION

The Company evaluates reporting segments in accordance with FASB ASC 280, “Segment Reporting”. The Company develops, manufactures, and sells devices designed primarily for the surgical ablation of cardiac tissue and systems designed for the exclusion of the left atrial appendage. These devices are developed and marketed to a broad base of medical centers in the United States and internationally. Management considers all such sales to be part of a single reportable segment. Revenue attributed to geographic areas is based on the location of the customers to whom products are sold.

Revenue by geographic area was as follows:

	Three Months Ended March 31,
	2015		2014
United States	$	22,923	$	18,143
Europe		4,416		4,308
Asia		2,300		2,292
Other international		247		104
Total international		6,963		6,704
Total revenue	$	29,886	$	24,847

Domestic revenue by product type was as follows:

	Three Months Ended March 31,
	2015		2014
Open-heart ablation	$	12,354	$	10,377
Minimally invasive ablation		4,347		3,448
AtriClip		5,503		3,620
Total ablation and AtriClip		22,204		17,445
Valve tools		719		698
Total domestic	$	22,923	$	18,143

International revenue by product type was as follows:

	Three Months Ended March 31,
	2015		2014
Open-heart ablation	$	4,216	$	3,971
Minimally invasive ablation		1,968		2,003
AtriClip		671		443
Total ablation and AtriClip		6,855		6,417
Valve tools		108		287
Total international	$	6,963	$	6,704

The majority of the Company’s long-lived assets are located in the United States.